Interleukin-22 drives endogenous thymic regeneration in mice

Jarrod A Dudakov1, Alan M Hanash, Robert R Jenq

  • 1Immunology Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA. dudakovj@mskcc.org

Science (New York, N.Y.)
|March 3, 2012
PubMed
Summary

Interleukin-22 (IL-22) drives thymic regeneration after injury by promoting thymic epithelial cell survival. This discovery offers new strategies for immune system repair and enhancing immune competence.